ctrl K

Watchlist Price Alert

Landos Biopharma Inc. (LABP)

NASDAQ: LABP · Real-Time Price · USD

22.93

0.13 (0.57%)

At close: May 23, 2024, 8:00 PM

Landos Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	37.55M	36.64M	8.3M	2.42M	9.81M	359K
Short-Term Investments	n/a	7.76M	82.58M	25.72M	40.16M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	26K	n/a	11K	n/a
Receivables	n/a	n/a	n/a	154K	1K	2.09M
Inventory	n/a	n/a	n/a	1.4M	n/a	n/a
Other Current Assets	491K	851K	1.27M	202K	144K	41K
Total Current Assets	38.04M	45.25M	92.15M	29.89M	50.11M	2.49M
Property-Plant & Equipment	n/a	n/a	707K	444K	359K	304K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	733K	444K	370K	304K
Total Assets	38.04M	45.25M	92.88M	30.33M	50.48M	2.8M
Account Payables	1.38M	3.44M	12.91M	8.61M	2.05M	1.69M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	4.87M	2.69M	3.7M	2.43M	978K	104K
Total Current Liabilities	6.25M	6.12M	16.61M	11.03M	3.03M	1.8M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	73.31M	n/a	n/a
Total Long-Term Liabilities	n/a	3.44M	n/a	73.31M	73.04M	n/a
Total Liabilities	6.25M	6.12M	16.61M	84.35M	76.06M	1.8M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	31K	403K	403K	71K	63K	59K
Retained Earnings	-155.36M	-133.43M	-94.15M	-55.73M	-25.59M	-9.13M
Comprehensive Income	n/a	-57K	-225K	10K	-77K	n/a
Shareholders Equity	31.79M	39.13M	76.27M	-54.02M	-25.58M	1M
Total Investments	n/a	7.76M	82.58M	25.72M	40.16M	n/a